<DOC>
	<DOCNO>NCT02861937</DOCNO>
	<brief_summary>Human IL-21 present gingival crevicular fluid periodontal health , gingivitis chronic periodontitis . A significant increase concentration IL-21 gingival crevicular fluid observe increase amount periodontal destruction . Non- surgical periodontal therapy aid decrease GCF IL-21 level clinical gingivitis chronic periodontitis</brief_summary>
	<brief_title>Estimation Interleukin-21 Levels Gingival Crevicular Fluid Patients With Periodontal Health Disease Following Non-surgical Periodontal Therapy : A Clinico-biochemical Study</brief_title>
	<detailed_description>Introduction Periodontal disease poly-microbial disease affect tooth-supporting tissues.1 Integral part periodontal disease involve destruction periodontal tissue result stimulation bacterial challenge host immune-inflammatory response . Chronic periodontitis common form periodontal disease adult population . The bacterial plaque biofilm primitive factor periodontitis , majority destruction periodontal tissue would eventually conclude sequence immune-inflammatory reaction . As result cellular activation , inflammatory mediator include cytokine , chemokines etc . collectively contribute tissue destruction bone resorption . Cytokines group Th1 , Th2 , Th17 T regulatory ( Treg ) base expression pattern effect target cell tissues.5 Classically , periodontal disease explain Th1/Th2 pathway . Th1 cell frequently detect early stage periodontal lesion suggest Th1 cell associate protective response bacterial infection whereas Th2 cell predominate later advanced period disease , role destruction progression periodontal lesion . Alternative type host response pathogenic bacteria describe IL-23/IL-17 pathway . This alternative pathway occur bacteria induce synthesis IL-23/17 rather IL-12 , play pivotal role initiation maintenance inflammatory response . IL-23/17 pathway compare classical Th1/Th2 pathway much fine tune cellular immune response multitude function bridge innate adaptive arm immune response.9 Th17 cytokine ( IL-17 , IL-21 , IL-22 , IL-6 , TNF-a , etc . ) 8 participate periodontal disease , whether dominant role host-protective destructive questionable . These cytokine elucidate different inflammatory status periodontitis . IL-21 type-I cytokine , structurally appear similar IL-2 , IL-4 , IL-15 proteins . IL-21 principally compose activated T cell , directs vast spectrum myeloid lymphoid cell immune system , facilitate IL-21 modulate acquire innate immunity.10 IL-21 compete immunity tumor cells11 chronic viral infections,12 however , enormous accomplishment IL-21 correlate advancement immune inflammatory diseases various organs.13 IL-21 heighten dermatological condition like skin biopsies14 patient systemic lupus erythematosus , psoriasis , atopic dermatitis . In addition , IL-21 interpretation correspond presence Th17 cell synovial fluid peripheral blood rheumatoid arthritis patient . Role IL-21 inflammation extensively study ; treatment aspect level periodontal disease need explore . Therefore , light finding , investigator determine level interleukin-21 ( IL-21 ) GCF chronic gingivitis , chronic periodontitis control patient non-surgical periodontal therapy along co-relation clinical parameter periodontal tissue destruction . MATERIAL AND METHODS : PATIENTS : Thirty four patient ( 19 male 15 female , age 20-60 year ) consecutively enrol six month period ( April 2014 September 2014 ) outpatient department periodontology , Krishnadevaraya College Dental Sciences , Bangalore , Karnataka . Ethical clearance study obtain institutional ethical committee ( 02-D012-36773 ) . The study conduct accordance ethical principle describe Declaration Helsinki 2008 . Procedure study explain informed write consent obtain participant inclusion study . Among , 24 patient diseased periodontium group 12 chronic gingivitis 12 chronic periodontitis patient whereas 10 healthy individual include control . Inclusion criterion : patient equal 14 functional teeth , systemically healthy patient receive form surgical non surgical periodontal therapy receive antibiotic non-steroidal anti-inflammatory therapy within past 6 month study . Chronic gingivitis define probe depth ( PD ) less equal 4mm , relative attachment loss ( RAL ) ) less equal 3mm 25 % site gingival bleed present ( BOP ) .15 Chronic periodontitis define probe depth equal 5mm , RAL equal 8mm , equal 10 % site BOP positive evidence bone loss determine radiographically.16 Patients volunteer evidence periodontal disease determine absence increase PD AL consider healthy control group . Clinical Measurements : Clinical parameter measure evaluated teeth exclude 3rd molar , six site tooth ( mesio-buccal , disto-buccal , disto-lingual , mid-lingual mesiolingual ) . These parameter consist pocket depth ( PD ) , assessment gingival bleed i.e gingival index ( GI ) , dichotomous measurement supragingival plaque accumulation i.e plaque index ( PI ) , bleed probe ( BOP ) base crevice . One caliberated examiner ( MN ) perform patient evaluation measurement . GCF sample collection analysis : In three group , GCF sample collect baseline 6 week post treatment . Site selection base high score record single site oral cavity . A single site subject show bad inflammatory manifestation ( chronic gingivitis ) high RAL level ( chronic periodontitis ) select gingival crevicular fluid collection . In study , select single site subject avoid pooling sample multiple site , periodontitis site specific disease . Prior collection GCF sample supragingival plaque remove cotton pellet avoid contact marginal gingiva . Standard paperstrips carefully insert depth approximately 2mm , sulcus/pocket 30 second collection GCF . Blood contaminate strip discard alternative site use obtain replacement sample . In chronic gingivitis patient , alternative sample wre collect next high GI score chronic periodontitis patient next deep PPD select alternative sample site . A calibrated appliance use quantify GCF sample volume read convert actual volume ( μL ) reference standard curve , prepare use periotron reading volume fluid ( μL ) distil water perio-col strip . A blank gingival fluid collection ( perio-col ) strip place periotron fluid meta sensor instrument adjust display read zero . A microlitre syringe use accurately deliver 0.25-1.25 μL fluid ( distilled water ) perio-col strip . The strip immediately place periotron sensor . The periotron score volume display known volume fluid record . This step repeat three time 0.25 μL test fluid average score record . The step repeat use volume 0.5 , 0.75 , 1.0 , 1.25 μL , every instance mean periotron value calculate record . Once score obtain , standard curve compute known fluid volume ( X-axis ) periotron score ( Y-axis ) . In similar way GCF volume ( health , chronic gingivitis , chronic perodontitis ) study patient obtain automatically periotron score . The interpolation standard caliberation graph give volume fluid . After measurement volume , strip select site place immediately individual microcentrifuge tube contain 200 μL phosphate buffer solution . The sample store -80 °C analysis . ELISA The level IL-21 GCF determine use ELISA accord manufacture instruction . To elute protein , tube contain periopaper strip vortexed homogenized 30 second centrifuge 12,500 rpm 4°C 5 minute . The kit use monoclonal antibody MT 21.3 biotin human recombinant IL-21 standard ( capture antibody ) . Samples run triplicate authenticate sensitivity ELISA sample find within detection limit ELISA . An ELISA reader ( spectramax 190 Ab sorbance microplate reader ; molecular device ; Sunnyvale , CA , USA ) 450 nm elementary wavelength use measure absorbance substrate . Conversion absorbance reading obtain , definite volume ( pg/mL ) perform use standard reference curve . The protein concentration site ( pg/mL ) determine divide total amount IL-21 ( pg ) gingival crevicular fluid volume ( μL ) subsequently ( pg/μL ) value convert ( pg/mL ) . Periodontal treatment protocol : At baseline , clinical parameter collection GCF sample patient do . All patient receive thorough oral hygiene instruction , full mouth supragingival subgingival scale along root plan . Non-surgical periodontal therapy group III perform 2-3 appointment . A single caliberated examiner ( MN ) provide treatment study patient . STATISTICAL ANALYSIS : The power study sample size calculation determine basis change GCF IL-21 level . Current estimate pilot study include 12 patient test group 10 control group total sample size 34 patient . Type II error level β = 0.20 ( 80 % power ) type I error level α=0.05 ( 5 % probability ) calculate . The distribution sample respective value PI , GI , BOP , PD , RAL IL-21 level pre-operatively post-operatively analyze statistically . Data enter Microsoft excel analyse use SPSS ( statistical package social science , ver.10.05 ) package . Proportions compare use Chi-square test ( χ2 ) test significance . Normality data test use Shapiro-Wilk test . A student t-test perform determine pre post treatment difference value . One way analysis variance ( ANOVA ) use test difference group . Comparison biochemical clinical parameter perform use Kruskal-Wallis non-parametric test . P &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Gingivitis</mesh_term>
	<criteria>patient equal 14 functional teeth , systemically healthy patient receive form surgical non surgical periodontal therapy receive antibiotic nonsteroidal antiinflammatory smoker pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>